These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 18777648)

  • 21. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
    Sagransky M; Yentzer BA; Feldman SR
    Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A treatment for severe nodular acne: a randomized investigator-blinded, controlled, noninferiority trial comparing fixed-dose adapalene/benzoyl peroxide plus doxycycline vs. oral isotretinoin.
    Tan J; Humphrey S; Vender R; Barankin B; Gooderham M; Kerrouche N; Audibert F; Lynde C;
    Br J Dermatol; 2014 Dec; 171(6):1508-16. PubMed ID: 24934963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-blind and comparative clinical study of the efficacy and safety of benzoyl peroxide 4% gel (BID) and adapalene 0.1% Gel (QD) in the treatment of acne vulgaris for 11 weeks.
    do Nascimento LV; Guedes AC; Magalhães GM; de Faria FA; Guerra RM; de C Almeida F
    J Dermatolog Treat; 2003 Sep; 14(3):166-71. PubMed ID: 14522627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Benzoyl peroxide microsphere cream as monotherapy and combination treatment of acne.
    Bikowski J; Del Rosso JQ
    J Drugs Dermatol; 2008 Jun; 7(6):590-5. PubMed ID: 18561594
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study.
    Thiboutot DM; Weiss J; Bucko A; Eichenfield L; Jones T; Clark S; Liu Y; Graeber M; Kang S;
    J Am Acad Dermatol; 2007 Nov; 57(5):791-9. PubMed ID: 17655969
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fixed-combination products in the management of acne vulgaris.
    Gold LS
    Cutis; 2010 Mar; 85(3):160-7. PubMed ID: 20408517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between sebostatic activity, tolerability and efficacy of three topical drugs to treat mild to moderate acne.
    Stinco G; Bragadin G; Trotter D; Pillon B; Patrone P
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):320-5. PubMed ID: 17309452
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of benzoyl peroxide 5% clindamycin combination gel versus adapalene 0.1% on quality of life in patients with mild to moderate acne vulgaris: a randomized single-blind study.
    Guerra-Tapia A
    J Drugs Dermatol; 2012 Jun; 11(6):714-22. PubMed ID: 22648218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment considerations for inflammatory acne: clinical evidence for adapalene 0.1% in combination therapies.
    Thiboutot DM; Gollnick HP
    J Drugs Dermatol; 2006 Sep; 5(8):785-94. PubMed ID: 16989194
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
    Dutil M
    Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acne therapy.
    White GM
    Adv Dermatol; 1999; 14():29-58; discussion 59. PubMed ID: 10643494
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combination.
    Bikowski JB
    J Drugs Dermatol; 2005; 4(2):164-71. PubMed ID: 15776773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization.
    Tanghetti EA; Popp KF
    Dermatol Clin; 2009 Jan; 27(1):17-24. PubMed ID: 18984364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A fixed-dose combination of adapalene 0.1%-BPO 2.5% allows an early and sustained improvement in quality of life and patient treatment satisfaction in severe acne.
    Brodell RT; Schlosser BJ; Rafal E; Toth D; Tyring S; Wertheimer A; Kerrouche N; Bucher D
    J Dermatolog Treat; 2012 Feb; 23(1):26-34. PubMed ID: 22103674
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Topical therapy for acne.
    Russell JJ
    Am Fam Physician; 2000 Jan; 61(2):357-66. PubMed ID: 10670502
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
    Ko HC; Song M; Seo SH; Oh CK; Kwon KS; Kim MB
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):245-50. PubMed ID: 19438817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Short-term combination therapy and long-term relapse prevention in the treatment of severe acne vulgaris.
    Tan J; Stein Gold L; Schlessinger J; Brodell R; Jones T; Cruz A; Kerrouche N; Jarratt M
    J Drugs Dermatol; 2012 Feb; 11(2):174-80. PubMed ID: 22270198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
    Tanghetti E; Abramovits W; Solomon B; Loven K; Shalita A
    J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Digital videography assessment of patients' experiences using adapalene-benzoyl peroxide gel in the treatment of acne vulgaris.
    Feldman SR; Fried RG; Herndon JH; Johnson L; Preston N; Gottschalk RW; Caveney SW
    J Drugs Dermatol; 2012 Aug; 11(8):919-25. PubMed ID: 22859236
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter randomized controlled trial on combination therapy with 0.1% adapalene gel and oral antibiotics for acne vulgaris: comparison of the efficacy of adapalene gel alone and in combination with oral faropenem.
    Hayashi N; Kawashima M
    J Dermatol; 2012 Jun; 39(6):511-5. PubMed ID: 22168326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.